Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 1.34M
2: EX-23.1 Consent of Expert or Counsel HTML 20K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 21K
12: R1 Cover HTML 51K
13: R2 Document And Entity Information HTML 66K
14: R3 Audit Information HTML 25K
15: R4 Consolidated Balance Sheets HTML 143K
16: R5 Consolidated Balance Sheets (Parenthetical) HTML 35K
17: R6 Consolidated Statements Of Operations HTML 95K
18: R7 Consolidated Statements Of Shareholders' Equity HTML 45K
and Comprehensive Loss
19: R8 Consolidated Statements Of Cash Flows HTML 89K
20: R9 Consolidated Statements Of Cash Flows HTML 41K
(Parenthetical)
21: R10 Organization and Description of Business HTML 26K
22: R11 Going concern (Notes) HTML 25K
23: R12 Significant Accounting Policies HTML 115K
24: R13 Intangible assets (Notes) HTML 42K
25: R14 Accrued expense (Notes) HTML 43K
26: R15 Line of credit (Notes) HTML 26K
27: R16 Long-term Debt (Notes) HTML 29K
28: R17 Capital Stock Transactions HTML 55K
29: R18 Income Taxes HTML 65K
30: R19 Commitments and Contingencies HTML 23K
31: R20 Retirement and post retirement plans (Notes) HTML 29K
32: R21 Related Party Transactions HTML 27K
33: R22 Concentration of credit risk (Notes) HTML 37K
34: R23 Leases (Notes) HTML 53K
35: R24 Significant Accounting Policies (Policies) HTML 153K
36: R25 Significant Accounting Policies (Tables) HTML 86K
37: R26 Significant Accounting Policies Property Plant and HTML 31K
Equipment (Tables)
38: R27 Significant Accounting Policies Deferred revenue HTML 29K
(Tables)
39: R28 Intangible assets (Tables) HTML 52K
40: R29 Accrued expense (Tables) HTML 31K
41: R30 Long-term Debt EIDL maturities (Tables) HTML 27K
42: R31 Income Taxes (Tables) HTML 61K
43: R32 Retirement and post retirement plans (Tables) HTML 29K
44: R33 Concentration of credit risk (Tables) HTML 34K
45: R34 Leases (Tables) HTML 44K
46: R35 Organization and Description of Business (Details) HTML 21K
47: R36 Going concern (Details) HTML 23K
48: R37 Significant Accounting Policies (Cash and Cash HTML 24K
Equivalents) (Details)
49: R38 Significant Accounting Policies (Inventory) HTML 33K
(Details)
50: R39 Significant Accounting Policies (Accounts HTML 27K
Receivable) (Details)
51: R40 Significant Accounting Policies (Net Income (loss) HTML 40K
Per Share) (Details)
52: R41 Significant Accounting Policies Earning per share HTML 71K
details (Details)
53: R42 Significant Accounting Policies Property pant and HTML 37K
equipment (Details)
54: R43 Significant Accounting Policies advertising HTML 21K
expense (Details)
55: R44 Significant Accounting Policies deferred revenue HTML 28K
(Details)
56: R45 Intangible assets (Details) HTML 43K
57: R46 Accrued expense (Details) HTML 36K
58: R47 Line of credit (Details) HTML 40K
59: R48 Long-term Debt (Details) HTML 47K
60: R49 Capital Stock Transactions (Stock Option Plans) HTML 58K
(Narrative) (Details)
61: R50 Capital Stock Transactions (Stock Option Activity) HTML 61K
(Details)
62: R51 Income Taxes (Provision for Income Taxes) HTML 27K
(Details)
63: R52 Income Taxes (Effective Income Tax Rate) (Details) HTML 30K
64: R53 Income Taxes (Components of Net Deferred Income HTML 57K
Tax Assets and Liabilities) (Details)
65: R54 Income Taxes Operation loss carry forward HTML 48K
(Details)
66: R55 Retirement and post retirement plans (Details) HTML 27K
67: R56 Retirement and post retirement plans - liability HTML 27K
rollforward (Details)
68: R57 Related Party Transactions (Details) HTML 38K
69: R58 Concentration of credit risk (Details) HTML 79K
70: R59 Leases (Details) HTML 49K
73: XML IDEA XML File -- Filing Summary XML 133K
71: XML XBRL Instance -- esmc-20220630_htm XML 1.28M
72: EXCEL IDEA Workbook of Financial Reports XLSX 117K
8: EX-101.CAL XBRL Calculations -- esmc-20220630_cal XML 119K
9: EX-101.DEF XBRL Definitions -- esmc-20220630_def XML 596K
10: EX-101.LAB XBRL Labels -- esmc-20220630_lab XML 1.45M
11: EX-101.PRE XBRL Presentations -- esmc-20220630_pre XML 930K
7: EX-101.SCH XBRL Schema -- esmc-20220630 XSD 130K
74: JSON XBRL Instance as JSON Data -- MetaLinks 371± 558K
75: ZIP XBRL Zipped Folder -- 0000862668-22-000023-xbrl Zip 361K
1.I have reviewed this annual report on Form 10-K for the fiscal year ended June 30, 2022 of Escalon Medical Corp.;
2.Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting
that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the
registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
